MediXall Group, Inc.
MediXall Group, Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Receivable Net | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | |||||
Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Intangible Assets Net | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 2 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Accounts Payable Related Parties Current | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 4 | 8 | 7 | 7 | 6 | 5 | 5 | 4 | 4 | 1 | 1 | 1 | |||||
Accrued Liabilities Current | 1 | - | - | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Notes Payable Current | 0 | 0 | 0 | - | - | - | - | - | - | - | - | 0 | |||||
Convertible Debt Current | 0 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 2 | 1 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Long Term Notes Payable | 0 | 0 | 0 | - | - | - | - | - | - | - | - | 0 | |||||
Liabilities | 4 | 8 | 7 | 7 | 6 | 5 | 5 | 5 | 4 | 3 | 2 | 1 | |||||
Commitments And Contingencies | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | -4 | -7 | -7 | -7 | -5 | -5 | -4 | -4 | -3 | -2 | -1 | -0 | |||||
Additional Paid In Capital | 35 | 31 | 31 | 31 | 30 | 30 | 29 | 29 | 28 | 28 | 27 | 25 | |||||
Retained Earnings Accumulated Deficit | -39 | -38 | -38 | -37 | -36 | -35 | -34 | -33 | -31 | -30 | -28 | -26 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Debt Instrument Unamortized Discount | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | |||||
Common Stock Shares Issued | 169 | 139 | 139 | 130 | 130 | 130 | 122 | 122 | 117 | 117 | 116 | 111 | |||||
Shares Outstanding | 169 | 139 | 139 | 130 | 130 | 130 | 122 | 122 | 117 | 117 | 116 | 111 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -97.44% | -97.44% | -97.44% | - | - | - |
| 2023 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 25.00% | 0.00% | 0.00% | 25.00% | 6.06% | 6.06% | 18.18% |
| 2022 | - | - | - | - | - | - | 0.55% | 20.75% | 13.21% | 133.33% | 133.33% | 133.33% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.14 | 0.18 | 0.28 | |||||
| Quick Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.14 | 0.09 | 0.05 | |||||
| Working Capital | -3.75M | -7.64M | -7.15M | -6.71M | -5.69M | -5.31M | -4.98M | -4.33M | -3.60M | -1.15M | -1.01M | -882.39K | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.06 | -1.03 | -1.04 | -1.03 | -1.09 | -1.10 | -1.14 | -1.23 | -1.35 | -1.66 | -2.81 | -4.33 | |||||
| Interest Coverage TTM | - | -97.60 | -58.22 | -27.38 | -10.22 | -11.48 | -14.13 | -24.19 | - | - | - | - | |||||
| Debt Ratio | 17.45 | 33.69 | 26.80 | 33.44 | 12.52 | 10.84 | 8.07 | 5.26 | 3.86 | 2.52 | 1.55 | 1.30 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.90 | 0.92 | 0.79 | 0.58 | 0.32 | 0.23 | 0.14 | 0.06 | 0.04 | 0.03 | 0.10 | 0.13 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.01 | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 | -0.05 | -0.06 | -0.06 | -0.06 | -0.07 | -0.06 | |||||
| Free Cash Flow Per Share TTM | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 | -0.04 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 57.29% | 46.67% | 43.52% | 23.56% | 20.02% | 34.36% | 30.82% | 100.00% | -2,612.89% | -6,033.84% | -1,229.84% | -1,596.83% | |||||
| Operating Profit Margin TTM | -710.77% | -1,007.51% | -1,094.80% | -1,474.82% | -2,079.95% | -2,661.35% | -4,365.81% | -11,524.63% | -14,908.61% | -24,683.94% | -3,926.83% | -3,431.15% | |||||
| Net Profit Margin TTM | -787.79% | -1,102.19% | -1,184.43% | -1,576.10% | -2,113.54% | -2,661.35% | -4,365.81% | -11,524.63% | -15,076.09% | -25,175.23% | -4,036.06% | -3,569.17% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 29.41% | 73.85% | 170.61% | 422.07% | 410.65% | 555.19% | -30.28% | -67.20% | -73.48% | -82.90% | 5,566.46% | - | |||||
| Net Income Growth (1Y) | -51.76% | -28.00% | -26.59% | -28.60% | -28.41% | -30.74% | -24.58% | 5.90% | 6.43% | 21.26% | 37.01% | 8.73% | |||||
| EPS Growth (1Y) | -61.21% | -33.90% | -33.08% | -34.50% | -35.87% | -36.88% | -29.25% | -5.41% | -3.53% | 6.57% | 21.18% | 3.20% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.04 | -0.02 | -0.01 | -0.01 | -0.06 | -0.02 | -1.73 | -10.93 | -2.86 | -6.35 | -30.65 | -16.96 | |||||
| P/B TTM | -0.03 | -0.01 | -0.01 | -0.01 | -0.05 | -0.02 | -2.24 | -20.35 | -6.81 | -26.34 | -339.38 | -321.69 | |||||
| P/S TTM | 0.32 | 0.17 | 0.15 | 0.16 | 1.17 | 0.40 | 75.64 | 1,259.78 | 431.48 | 1,599.18 | 1,236.86 | 605.45 | |||||
| Market Cap | 97.36K | 55.53K | 53.62K | 50.87K | 274.02K | 76.47K | 9.77M | 74.66M | 19.87M | 46.47M | 229.25M | 109.41M | |||||
| Enterprise Value | 655.67K | 4.79M | 4.48M | 3.87M | 3.91M | 3.42M | 12.72M | 77.22M | 21.81M | 47.64M | 229.57M | 109.35M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -1.20M | -1.07M | -1.09M | -1.23M | -1.63M | -2.26M | -2.88M | -3.56M | -3.96M | -3.95M | -4.52M | -4.69M | |||||
| Net Debt | 558.31K | 4.73M | 4.43M | 3.82M | 3.64M | 3.34M | 2.94M | 2.55M | 1.94M | 1.17M | 322.98K | -63.42K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
MediXall Group, Inc. (MDXL) — SEC Financial Statements & Analysis
MediXall Group, Inc. (MDXL) is a railroads, line-haul operating company, incorporated in NV. MediXall Group, Inc. trades on OTC as: MDXL. Based on its latest SEC filing (Form 10-Q, period ending 2024-09-30), MediXall Group, Inc. reported a 29.41% year-over-year revenue growth, a Gross Profit Margin of 57.29% (TTM), a Debt-to-Equity ratio of -1.06x, a Price-to-Sales (P/S) ratio of 0.32x (TTM), a Price-to-Book (P/B) ratio of -0.03x (TTM), at a market cap of $97.36K. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 29.41%
- Gross Profit Margin TTM
- 57.29%
- Debt To Equity
- -1.06x
- P/S TTM
- 0.32x
- P/B TTM
- -0.03x
- Market Cap
- $97.36K
Data as of 2024-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MediXall Group, Inc. in?
MediXall Group, Inc. (MDXL) operates in the Railroads, Line-Haul Operating industry.
What is MDXL's market cap?
MediXall Group, Inc. (MDXL) has a market capitalization of $97.36K as of 2024-09-30.
What exchange does MDXL trade on?
MediXall Group, Inc. (MDXL) trades on the OTC.
Where is MediXall Group, Inc. incorporated?
MediXall Group, Inc. is incorporated in NV.